Vonoprazan
Back to searchMolecule Structure
Scientific Name
Vonoprazan
Description of the Drug
Vonoprazan is a potassium-competitive acid blocker used in the treatment of acid-related disorders and as an adjunct to Helicobacter pylori eradication.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11739
http://www.drugbank.ca/drugs/DB11739
Brand Name(s)
Takecab, Vocinti
Company Owner(s)
Phathom Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Potassium-transporting ATPase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2095173 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL194487 |
Human Metabolome Database | HMDB0259872 |
DrugBank | DB11739 |
PubChem: Thomson Pharma | 24260313 |
PubChem | 15981397 |
Nikkaji | J2.908.904C |
PDBe | HKT |
BindingDB | 394392 |
EPA CompTox Dashboard | DTXSID20236869 |
DrugCentral | 4993 |
ChemicalBook | CB22716734 |
ChEBI | 136048 |
ZINC | ZINC000034842823 |